Corrigendum to “Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit”

Cammarota A, Joshi K, Aghayeva F, et al. Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit. Therapeutic Advances in Medical Oncology. 2025;17. doi:10.1177/17588359251318864

In the above referenced article, the names of the authors have been corrected to “Antonella Cammarota, Kroopa Joshi, Farah Aghayeva, Rachel Woodford, Rafael Grochot, Anja Williams, Elizabeth Catherine Smyth and Elisa Fontana”

The referenced article has been updated online.